Dianthus Therapeutics Inc...
20.21
0.34 (1.69%)
At close: Jan 15, 2025, 9:47 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 2.83M 6.42M 1.48M n/a n/a n/a n/a n/a
Cost of Revenue 355.00K 147.00K 2.02M 1.98M 1.84M 875.00K 376.00K 6.00K
Gross Profit 2.47M 6.27M -544.00K -1.98M -1.84M -875.00K -376.00K -6.00K
Operating Income -48.17M -29.70M -13.09M -78.70M -82.97M -59.96M -35.73M -9.27M
Interest Income 4.76M 1.15M 3.00K 3.77M n/a 2.45M 236.00K n/a
Pretax Income -43.55M -28.48M -13.11M -74.94M -76.77M -57.52M -35.49M -9.43M
Net Income -43.55M -28.48M -13.11M -74.94M -76.77M -57.52M -35.49M -9.43M
Selling & General & Admin 18.16M 6.74M 1.96M 28.09M 23.76M 17.75M 7.45M 3.48M
Research & Development 32.84M 29.38M 12.61M 48.64M 57.37M 41.34M 27.90M 5.78M
Other Expenses n/a -52.00K n/a n/a n/a n/a n/a n/a
Operating Expenses 51.00M 36.12M 14.56M 76.72M 81.13M 59.09M 35.35M 9.26M
Interest Expense n/a n/a 3.56M 3.77M n/a n/a n/a 163.00K
Selling & Marketing Expenses n/a n/a n/a n/a n/a -875.00K -376.00K -6.00K
Cost & Expenses 51.00M 36.12M 14.56M 78.70M 82.97M 59.96M 35.73M 9.27M
Income Tax n/a -1.28M -2.00M 7.53M 6.20M 2.45M 236.00K n/a
Shares Outstanding (Basic) 5.15M 3.75M 3.43M 2.75M 2.31M 1.15M 2.21M 2.21M
Shares Outstanding (Diluted) 5.15M 3.75M 3.43M 2.75M 2.31M 1.15M 2.21M 2.21M
EPS (Basic) -8.45 -7.6 -3.82 -27.3 -33.18 -27.62 -16.05 -4.27
EPS (Diluted) -8.45 -7.6 -3.82 -27.3 -33.18 -27.62 -16.05 -4.27
EBITDA -48.17M -29.56M -13.09M -72.96M -74.93M -56.64M -35.12M -9.26M
Depreciation & Amortization 355.00K 147.00K 2.02M 1.98M 1.84M 875.00K 376.00K 6.00K

Create Price Alert on DNTH

Your price alert will notify you when the stock price is above 20.21.

Add to Watchlist